Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 76

Sort by

Sort Order Select

Journal Articles

Outcomes of Primary and Secondary Prophylaxis of Chemotherapy Induced and Febrile Neutropenia (CIN/FN) in Bendamustine Plus Rituximab (BR) Regimens in Patients with Lymphoma and Chronic Lymphocytic Leukemia (CLL): Real-World, Single-Center Experience

Logan Moore, Trace Bartels, BS, Daniel O. Persky, MD, Abhijeet Kumar, Ivo Abraham, PhD RN, Lauren Sanders, PharmD, Alicia Ortega, PharmD, Alyssa Henglefelt, PharmD, Ali McBride, PharmD,MS

Blood (2019) 134 (Supplement_1): 5353.

https://doi.org/10.1182/blood-2019-132148

Published: 2019

Journal Articles

A Randomized Controlled Clinical Study of Peg-Rhg-CSF for Preventing Chemotherapy-Induced Neutropenia in Patients with B-Cell Non-Hodgkin Lymphoma

Changqing Zhen, MD, Mei Ding, Kang Lu, MD PhD, Xueling Ge, PhD, Na Chen, MD, Xiaosheng Fang, MD, Xiaohui Sui, Jiang Yujie, MD, Xin Liu, Ying Li, Xianghua Wang, Ying Li, MD, Lingyan Zhang, MD, Hongzhi Xu, Juan Fan, MD, Xin Wang, MD PhD

Blood (2019) 134 (Supplement_1): 5323.

https://doi.org/10.1182/blood-2019-128438

Published: 2019

Journal Articles

Outcomes of Isolated Neutropenia Referred to Pediatric Hematology Oncology Clinic

Vishnu Nagalapuram, MBBS, David McCall, MD, Prasannalaxmi Palabindela, MD, Christina Bemrich Stolz, MD, Thomas H. Howard, MD, Jeffrey D. Lebensburger, DO, MSPH, Lee Hilliard, MD

Blood (2019) 134 (Supplement_1): 5858.

https://doi.org/10.1182/blood-2019-126274

Published: 2019

Journal Articles

Impact of Primary Antibacterial Prophylaxis on Neutropenic Fever, Infections, and Antimicrobial Resistance in Newly Diagnosed AML Patients

Jessica Caro, MD, Erin Moshier, MS, Douglas Tremblay, MD, Alexander Coltoff, MD, Guido Lancman, MD, Meenakshi Rana, MD, John Mascarenhas, MD, Samantha Jacobs, MD

Blood (2019) 134 (Supplement_1): 3849.

https://doi.org/10.1182/blood-2019-123435

Published: 2019

Journal Articles

Retrospective Review of Appropriate Use of Antimicrobials and Anticoagulants in Patients Hospitalized for a Malignant Hematologic Condition

Louis-Bassett Porter, MD, Hanaa Shihadeh, Kim Dittus, MD PhD

Blood (2019) 134 (Supplement_1): 2116.

https://doi.org/10.1182/blood-2019-121534

Published: 2019

Journal Articles

Severe Chronic Neutropenia in the Large Granular Lymphocyte Syndrome: Outcomes in Response to Granulocyte Colony Stimulating Factor (G-CSF) and Immunosuppressive Therapies

David C. Dale, MD, James A. Shannon, IV, Audrey Anna Bolyard, RN, BS, Jim Connelly, MD, Daniel C. Link, MD, Mary Ann Bonilla, MD, Peter E. Newburger, MD

Blood (2019) 134 (Supplement_1): 3589.

https://doi.org/10.1182/blood-2019-126181

Published: 2019

Journal Articles

A Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim (Dulastin®) after Single Administration in Pediatric Patients

Kyung Taek Hong, MD, Soyoung Lee, Jaeseong Oh, Jung Yoon Choi, MD, Hee Young Shin, MD PhD, Kyung-Sang Yu, MD PhD, Hyoung Jin Kang, MD PhD

Blood (2019) 134 (Supplement_1): 3594.

https://doi.org/10.1182/blood-2019-125266

Published: 2019

Journal Articles

Neutropenia in Myelosuppressed Cancer Patients Treated with Recombinant Human Erythropoietin (EPO)

Daniel G. Wright, MD, Elizabeth C. Wright, PhD MPH, Constance Tom Noguchi, PhD

Blood (2019) 134 (Supplement_1): 1034.

https://doi.org/10.1182/blood-2019-126650

Published: 2019

Journal Articles

Cost-Effective Use of White Blood Cell Growth Factors in the Veterans Administration

Kevin Knopf, MD, William Hrureshky, Bryan Love, Leann Norris, Charles L. Bennett, MD PhD

Blood (2018) 132 (Supplement 1): 4761.

https://doi.org/10.1182/blood-2018-99-119724

Published: 2018

Journal Articles

Autoimmune Neutropenia of Infancy- Unexpected Prevalence of Pseudomonas Skin Infections

Joanne Yacobovich, MD, Neta Aviran Dagan, MD, Tracie Goldberg, MD, Orna Steinberg Shemer, MD MSc, Hannah Tamary, MD

Blood (2018) 132 (Supplement 1): 4940.

https://doi.org/10.1182/blood-2018-99-113408

Published: 2018

Journal Articles

Plinabulin, a Novel Small Molecule in Development for Chemotherapy-Induced-Neutropenia (CIN) Prevention, Mobilizes CD34+ Cells through a Mechanism of Action (MoA) Different from G-CSF and from CXCR4 Inhibition

Douglas W. Blayney, MD, Ene Ette, PhD, Stephan Ogenstad, PhD, Yuankai Shi, MD PhD, Lihua Du, Kenneth Lloyd, PhD, Lan Huang, PhD, Ramon Mohanlal, PhD MD

Blood (2018) 132 (Supplement 1): 2068.

https://doi.org/10.1182/blood-2018-99-113569

Published: 2018

Journal Articles

Comparability of Pharmacodynamics and Immunogenicity of B12019, a Proposed Pegfilgrastim Biosimilar to Neulasta

Karsten Roth, Né Meyer, MDPhD, Hendrik Wessels, Josef Hoefler, Rüdiger Jankowsky

Blood (2017) 130 (Supplement 1): 1002.

https://doi.org/10.1182/blood.V130.Suppl_1.1002.1002

Published: 2017

Journal Articles

A Comparison of Levofloxacin and Oral Third Generation Cephalosporins As Antibacterial Prophylaxis in Acute Myeloid Leukemia (AML) during Chemotherapy-Induced Neutropenia

Kristyn E. Yemm, PharmD, Jason N. Barreto, PharmD, Ross A. Dierkhising, MS, Kristin C. Mara, MS, Naseema Gangat, MBBS, Pritish K. Tosh, MD

Blood (2016) 128 (22): 3986.

https://doi.org/10.1182/blood.V128.22.3986.3986

Published: 2016

Journal Articles

Plinabulin, a Novel Small Molecule That Ameliorates Chemotherapy-Induced Neutropenia, Is Administered on the Same Day of Chemotherapy and Has Anticancer Efficacy

Douglas W Blayney, MD, Lyudmila Bazhenova, MD, G. Kenneth Lloyd, PhD, Lan Huang, PhD, Ramon Mohanlal, MD PhD

Blood (2016) 128 (22): 2508.

https://doi.org/10.1182/blood.V128.22.2508.2508

Published: 2016

Journal Articles

Chemotherapy Efficacy on Human Breast Cancer Xenograft in Mice Remains Effective in Combination with Myelo001, a Novel Orally Bioavailable Small Molecule to Treat Myelosuppression

Patrik PK Brehm, MSc, Neeta Donnimath, MSc, Dirk Pleimes, MD

Blood (2016) 128 (22): 5068.

https://doi.org/10.1182/blood.V128.22.5068.5068

Published: 2016

Journal Articles

Demonstration of Pharmacokinetic and Pharmacodynamic Equivalence in Healthy Volunteers for B12019, a New Proposed Pegfilgrastim Biosimilar

Karsten Roth, Barbara Gastl, Dirk Lehnick, Karin Jacob, Ruediger Jankowsky

Blood (2016) 128 (22): 5079.

https://doi.org/10.1182/blood.V128.22.5079.5079

Published: 2016

Journal Articles

Control of Neutrophil Endothelial Transmigration By EC-18 in Chemotherapy Induced Neutropenia

Jae Wha Kim, PhD, Yong-Jae Kim, Young-Jun Kim, PhD, Sun Young Yoon, PhD, Jinseon Jeong, Young-Eun Ko, Su-Hyun Shin, Nina Yoo, Myung-Hwan Kim, MD PhD, Cheolwon Suh, MD PhD, Ki-Young Sohn, Heung-Jae Kim, PhD, Yong-Hae Han, PhD, Saeho Chong, PhD

Blood (2015) 126 (23): 2210.

https://doi.org/10.1182/blood.V126.23.2210.2210

Published: 2015

Journal Articles

Relationship Between Severity and Duration of Chemotherapy Induced Neutropenia and Risk of Infection Among Patients with Non-Myeloid Malignancies

Yanli Li, MDPhD, Xiaolong Shih, PhD, Zandra K. Klippel, MD, Maureen Reiner, M.S., John H Page, MD ScD

Blood (2014) 124 (21): 4960.

https://doi.org/10.1182/blood.V124.21.4960.4960

Published: 2014

Journal Articles

Mobilisation of PBSC for Allogenic Transplantation By the Use of G-CSF Biosimilar Zarzio® in Healthy Donors

Javier Anguita, Pascual Balsalobre, Elena González-Arias, Sara Redondo, Ana Pérez-Corral, MD, Cristina Pascual, David Serrano, MD, Mi Kwon, MD, Mariana Bastos, Cristina MuÃ±oz, Jorge Gayoso, MD, Jose Luis Diez-Martin, MD PhD

Blood (2014) 124 (21): 5824.

https://doi.org/10.1182/blood.V124.21.5824.5824

Published: 2014

Journal Articles

A Comparison of Proposed Biosimilar and Originator Filgrastim for the Prevention of Neutropenia in Patients with Breast Cancer Receiving Myelosuppressive Adjuvant or Neoadjuvant Chemotherapy: Phase III, Randomized, Double-Blind Trial (The PIONEER study)

Kimberly Blackwell, Vladimir Semiglazov, Pedro Gascon, Roumen Nakov, Stefan Kramer, Arnd Schwebig, MD, Nadia Harbeck

Blood (2014) 124 (21): 5133.

https://doi.org/10.1182/blood.V124.21.5133.5133

Published: 2014

NARROW

Outcomes of Primary and Secondary Prophylaxis of Chemotherapy Induced and Febrile Neutropenia (CIN/FN) in Bendamustine Plus Rituximab (BR) Regimens in Patients with Lymphoma and Chronic Lymphocytic Leukemia (CLL): Real-World, Single-Center Experience

A Randomized Controlled Clinical Study of Peg-Rhg-CSF for Preventing Chemotherapy-Induced Neutropenia in Patients with B-Cell Non-Hodgkin Lymphoma

Outcomes of Isolated Neutropenia Referred to Pediatric Hematology Oncology Clinic

Impact of Primary Antibacterial Prophylaxis on Neutropenic Fever, Infections, and Antimicrobial Resistance in Newly Diagnosed AML Patients

Retrospective Review of Appropriate Use of Antimicrobials and Anticoagulants in Patients Hospitalized for a Malignant Hematologic Condition

Severe Chronic Neutropenia in the Large Granular Lymphocyte Syndrome: Outcomes in Response to Granulocyte Colony Stimulating Factor (G-CSF) and Immunosuppressive Therapies

A Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim (Dulastin®) after Single Administration in Pediatric Patients

Neutropenia in Myelosuppressed Cancer Patients Treated with Recombinant Human Erythropoietin (EPO)

Cost-Effective Use of White Blood Cell Growth Factors in the Veterans Administration

Autoimmune Neutropenia of Infancy- Unexpected Prevalence of Pseudomonas Skin Infections

Plinabulin, a Novel Small Molecule in Development for Chemotherapy-Induced-Neutropenia (CIN) Prevention, Mobilizes CD34+ Cells through a Mechanism of Action (MoA) Different from G-CSF and from CXCR4 Inhibition

Comparability of Pharmacodynamics and Immunogenicity of B12019, a Proposed Pegfilgrastim Biosimilar to Neulasta

A Comparison of Levofloxacin and Oral Third Generation Cephalosporins As Antibacterial Prophylaxis in Acute Myeloid Leukemia (AML) during Chemotherapy-Induced Neutropenia

Plinabulin, a Novel Small Molecule That Ameliorates Chemotherapy-Induced Neutropenia, Is Administered on the Same Day of Chemotherapy and Has Anticancer Efficacy

Chemotherapy Efficacy on Human Breast Cancer Xenograft in Mice Remains Effective in Combination with Myelo001, a Novel Orally Bioavailable Small Molecule to Treat Myelosuppression

Demonstration of Pharmacokinetic and Pharmacodynamic Equivalence in Healthy Volunteers for B12019, a New Proposed Pegfilgrastim Biosimilar

Control of Neutrophil Endothelial Transmigration By EC-18 in Chemotherapy Induced Neutropenia

Relationship Between Severity and Duration of Chemotherapy Induced Neutropenia and Risk of Infection Among Patients with Non-Myeloid Malignancies

Mobilisation of PBSC for Allogenic Transplantation By the Use of G-CSF Biosimilar Zarzio® in Healthy Donors

A Comparison of Proposed Biosimilar and Originator Filgrastim for the Prevention of Neutropenia in Patients with Breast Cancer Receiving Myelosuppressive Adjuvant or Neoadjuvant Chemotherapy: Phase III, Randomized, Double-Blind Trial (The PIONEER study)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only